Physicswallah posted its highest-ever quarterly revenue of ₹1,242 crore, up 18.2 per cent year-on-year (YoY), and its consolidated profit doubled, rising 106 per cent YoY to ₹144 crore.
MOFSL has increased its earnings estimates by 3 per cent and 5 per cent for FY27 and FY28, respectively, factoring in the strong volume trajectory witnessed in October.
Lenskart stock, which was listed on the bourse on November 10 last year, has nearly doubled investors' money as it trades 90 per cent above its issue price of ₹402.
On BSE, the shares listed at a 12.2 per cent premium at ₹92.02. On NSE, the shares listed at a premium of 10.98 per cent to ₹91
During Samvat 2082 (October 21, 2025, to November 4, 2026), the mainboard IPO market saw 129 issues, which together raised ₹2.12 trillion.
Tech analysts caution that the recent pullback in Nifty should not be considered as a trend reversal, and reckon that only a move beyond 24,780 could signal an improvement in the overall market trend.
The performance in the month following Muhurat trading has been less consistent than the session-day trend
Investors with a long-term horizon could deploy around 40-50 per cent of their intended allocation upfront, said Siddhartha Khemka.
Bharti Airtel, ONGC, Titan Company, Mahindra & Mahindra, Britannia Industries and LIC will announce their Q2 results today, among other companies
Stocks to buy, Nifty strategy: Ajit Mishra has said that Nifty will likely build a stronger base and inch towards 24,200 next, followed by 24,400-24,700. He has recommended GAIL and HAL shares to buy
Stocks to buy today: Jatin Gedia of Teji Mandi Investment said Hitachi Energy, KFin Technologies, and Jubilant FoodWorks are flashing bullish technical signals.
Stock market outlook: Analysts said Samvat 2083 will be tested by a combination of global macroeconomic pressures, geopolitical uncertainty and domestic growth challenges.
According to ACE Equity data, a total of 16 stocks turned multibagger from the Nifty 500 universe in Samvat 2082.
NSE share price target: Following the Q2 results, Jefferies has maintained its 'Buy' rating on NSE shares, and raised the target price to ₹2,125 from ₹2,085.
Alembic Pharma's revenue from operations increased by 36 per cent YoY to ₹2,603 crore during the said period from ₹1,910 crore a year ago.
Motilal Oswal Financial Services has reiterated its 'Buy' rating on BEL stock and revised its target price to ₹540 from the earlier target of ₹530.
The issue, which opened for subscription on October 29 and closed on November 2, received a strong response from investors. It was subscribed 63.89 times overall.
The maker of Gowardhan Ghee and Go Cheese, Parag Milk Foods, posted its highest-ever quarterly revenue during the quarter under review.
Equitas SFB shares rallied 9 per cent after board approved the appointment of Balaji Nuthalapadi as its interim CEO, subject to the approval of the Reserve Bank of India.
Titan is expected to post 16-18.8 per cent revenue growth and 20-26.8 per cent profit growth in Q2FY27.